tryptophan has been researched along with Scleroderma, Systemic in 50 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 26 (52.00) | 18.7374 |
1990's | 19 (38.00) | 18.2507 |
2000's | 2 (4.00) | 29.6817 |
2010's | 3 (6.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Furue, M; Hashimoto-Hachiya, A; Mitoma, C; Murai, M; Tsuji, G; Yamamura, K | 1 |
Campochiaro, C; Denton, CP; Fuchs, D; Lytton, S; Nihtyanova, S; Ong, VH | 1 |
Del Bufalo, A; Del Papa, N; Filippini, P; Locatelli, F; Rutella, S; Sambataro, D | 1 |
BROWN, RR; JOHNSON, SA; MENDELSON, C; PRICE, JM; RUKAVINA, JG | 1 |
BIRK, RE; RUPE, CE | 1 |
PINALS, RS | 1 |
BEETHAM, W; FISCHER, S; SCHROHENLOHER, R | 1 |
Lipko-Godlewska, S; Wielowieyska-Szybińska, D; Wojas-Pelc, A | 1 |
Brown, RR; Johnson, AM; Price, JM; Yess, N | 1 |
Guillevin, L; Ortonne, JP | 1 |
Berry, CL | 1 |
Meurer, M; Szeimies, RM | 1 |
Kondo, H | 1 |
Jablońska, S; Skiendzielewska, A; Stachow, A | 2 |
Jabłońska, S; Skiendzielewska, A; Stachów, A | 1 |
Kimmig, J; Kreysel, HW; Meyerhoff, K | 1 |
Allegri, G; Costa, C; Crepaldi, G; De Antoni, A; Muggeo, M | 1 |
De Bruin, E; Hankes, LV; Jansen, CR; Schmaeler, M; Vorster, L | 1 |
Gliński, W; Jarzabek-Chorzelska, M; Stachów, A | 1 |
Brown, RR; Hankes, LV; Jansen, CR; Leklem, JE | 1 |
Hankes, LV; Schmaeler, M | 1 |
Golitz, LE; Guerin, SB; Kulik, JE; Schmidt, JJ | 1 |
Harati, Y; Heyes, MP; McKinley, K; Quearry, B; Silver, RM; Smith, EA; Sternberg, EM | 1 |
Mensing, H | 1 |
Carreira, P; Heyes, MP; Silver, RM; Sutherland, SE | 1 |
Heyes, MP; Maize, JC; Quearry, B; Silver, RM; Sternberg, EM; Vionnet-Fuasset, M | 1 |
Hefti, U; Steiger, U | 1 |
Braun-Falco, O; Krieg, T; Meurer, M; von Gizycki-Nienhaus, B | 1 |
Gross, WL; Reinhold-Keller, E; Schnabel, A; Wolff, HH | 1 |
Greenwald, R; Hirschfield, L; Schlessel, K | 1 |
Lacour, JP; Ortonne, JP | 1 |
Plewig, G; Reinauer, S | 1 |
Bammel, A; Burg, G; Elsner, P; Lurz, C; Zillikens, D | 1 |
James, TN; Kamb, ML; Kilbourne, EM; Sandberg, GA; Silver, RM | 1 |
Connolly, SM; Griffing, WL; Quimby, SR; Winkelmann, RK | 1 |
Frey, R; Frick, P | 1 |
Jimenez, S; Peltonen, J; Uitto, J; Varga, J | 1 |
Freundlich, B; Leyden, JJ; O'Connor, CR; Rook, AH; Schumacher, HR; Stolley, PD; Werth, VP | 1 |
Blétry, O; Cadranel, J; Francès, C; Godeau, P | 1 |
Brown, RR; Price, JM; Rose, DP; Wolf, H | 1 |
Houpt, JB; Hunt, M; Ogryzlo, MA | 1 |
Jablonska, S; Stachow, A | 1 |
Calandra, P | 1 |
Binazzi, M; Calandra, P | 1 |
Brown, RR; Hankes, LV; Jesseph, J; Leklem, J; Schmaeler, M | 1 |
Haustein, UF; Sönnichsen, N | 1 |
Jablonska, S | 1 |
Feuerstein, M; Kölzsch, J; Sönnichsen, N | 1 |
Drummond, KN; Good, RA; Michael, AF | 1 |
6 review(s) available for tryptophan and Scleroderma, Systemic
Article | Year |
---|---|
Emerging concepts on inhibitors of indoleamine 2,3-dioxygenase in rheumatic diseases.
Topics: Animals; Arthritis, Rheumatoid; Enzyme Inhibitors; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Lupus Erythematosus, Systemic; Rheumatic Diseases; Scleroderma, Systemic; Sjogren's Syndrome; Tryptophan | 2012 |
[Eosinophilic fasciitis--current database].
Topics: Diagnosis, Differential; Eosinophilia; Fasciitis; Female; Humans; Hypergammaglobulinemia; Male; Scleroderma, Localized; Scleroderma, Systemic; Tryptophan | 2004 |
[Treatment of scleroderma].
Topics: Adrenal Cortex Hormones; Blood Circulation; Collagen; Fibroblasts; Humans; Immunosuppressive Agents; Scleroderma, Systemic; Tryptophan | 1983 |
[Scleroderma, scleroderma related diseases].
Topics: Aniline Compounds; Animals; Bleomycin; Carbidopa; Diagnosis, Differential; Eosinophilia-Myalgia Syndrome; Epoxy Resins; Humans; Occupational Exposure; Polyvinyl Chloride; Prognosis; Scleroderma, Systemic; Silicon Dioxide; Silicones; Solvents; Tryptophan | 2000 |
[Myalgia-hypereosinophilia syndrome caused by L-tryptophan].
Topics: Adrenal Cortex Hormones; Centers for Disease Control and Prevention, U.S.; Eosinophilia; Humans; Muscular Diseases; Nervous System Diseases; Pain; Pruritus; Scleroderma, Systemic; Syndrome; Tryptophan; United States | 1990 |
[Physiopathologic bases of the treatment of systemic scleroderma].
Topics: Blood Platelets; Collagen; Connective Tissue; Endothelium; Fibroblasts; Humans; Lymphocytes; Macromolecular Substances; Macrophages; Scleroderma, Systemic; Tryptophan | 1986 |
44 other study(ies) available for tryptophan and Scleroderma, Systemic
Article | Year |
---|---|
Tryptophan photo-product FICZ upregulates AHR/MEK/ERK-mediated MMP1 expression: Implications in anti-fibrotic phototherapy.
Topics: Basic Helix-Loop-Helix Transcription Factors; Carbazoles; Cells, Cultured; Dermis; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Receptors, Aryl Hydrocarbon; RNA, Messenger; RNA, Small Interfering; Scleroderma, Systemic; Tissue Inhibitor of Metalloproteinases; Tryptophan; Ultraviolet Therapy; Up-Regulation | 2018 |
Elevated kynurenine levels in diffuse cutaneous and anti-RNA polymerase III positive systemic sclerosis.
Topics: Autoantibodies; Female; Humans; Hypertension, Pulmonary; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Male; Middle Aged; RNA Polymerase III; Scleroderma, Diffuse; Scleroderma, Systemic; Tryptophan | 2019 |
Scleroderma (acrosclerosis). II. Tryptophan metabolism before and during treatment by Chelaton (EDTA).
Topics: Edetic Acid; Humans; Scleroderma, Systemic; Tryptophan | 1957 |
Systemic sclerosis. Fourteen cases treated with chelation (disodium EDTA) and/or pyridoxine, with comments on the possible role of altered tryptophan metabolism in pathogenesis.
Topics: Basidiomycota; Chelating Agents; Edetic Acid; Humans; Pyridoxine; Scleroderma, Localized; Scleroderma, Systemic; Tryptophan | 1962 |
TRYPTOPHAN METABOLISM IN RHEUMATIC DISEASE.
Topics: Amino Acids; Arthritis; Arthritis, Rheumatoid; Chromatography; Humans; Kynurenic Acid; Kynurenine; Lupus Erythematosus, Systemic; ortho-Aminobenzoates; Rheumatic Diseases; Scleroderma, Systemic; Tryptophan; Urine; Xanthurenates | 1964 |
TRYPTOPHAN METABOLITE EXCRETION IN CONNECTIVE TISSUE DISEASES DEMONSTRATING A DIFFERENCE BETWEEN RHEUMATOID SPONDYLITIS AND RHEUMATOID ARTHRITIS.
Topics: Arthritis; Arthritis, Rheumatoid; Connective Tissue Diseases; Diagnosis, Differential; Humans; Kynurenine; Lupus Erythematosus, Systemic; Metabolism; Scleroderma, Systemic; Spondylitis; Spondylitis, Ankylosing; Tryptophan; Urine | 1964 |
Tryptophan metabolism. A hitherto unreported abnormality occurring in a family.
Topics: Chlorotrianisene; Electroencephalography; Female; Humans; Injections, Intramuscular; Kynurenine; Male; Metabolism, Inborn Errors; Pyridoxine; Scleroderma, Systemic; Tryptophan | 1967 |
Of faddism, toxic oil, and scleroderma.
Topics: Adult; Brassica; Diet Fads; Eosinophilia-Myalgia Syndrome; Fatty Acids, Monounsaturated; Female; Humans; Middle Aged; Plant Oils; Rapeseed Oil; Scleroderma, Systemic; Tryptophan | 1993 |
[The tryptophan-associated eosinophilia-myalgia syndrome. A clinical follow-up of 8 patients].
Topics: Aged; Biopsy; Drug Therapy, Combination; Eosinophilia-Myalgia Syndrome; Female; Follow-Up Studies; Humans; Male; Middle Aged; Muscles; Myxedema; Scleroderma, Systemic; Skin; Tryptophan | 1993 |
Intestinal absorption of L-tryptophan in scleroderma.
Topics: Adolescent; Adult; Aged; Biopsy; Female; Humans; Indican; Indoleacetic Acids; Intestinal Absorption; Intestine, Small; Male; Middle Aged; Protein Binding; Scleroderma, Systemic; Serum Albumin; Tryptophan; Xylose | 1976 |
Biogenic amines derived from tryptophan in systemic and cutaneous scleroderma.
Topics: Colorimetry; Female; Humans; Hydroxyindoleacetic Acid; Indoleacetic Acids; Male; Monoamine Oxidase; Scleroderma, Localized; Scleroderma, Systemic; Serotonin; Spectrometry, Fluorescence; Tryptamines; Tryptophan | 1979 |
[Tryptophan-load in progressive scleroderma (author's transl)].
Topics: 3-Hydroxyanthranilic Acid; Female; Humans; Hydroxyindoleacetic Acid; Indoleacetic Acids; Kynurenine; Male; Niacinamide; Scleroderma, Systemic; Serotonin; Skin; Tryptamines; Tryptophan; Xanthurenates | 1976 |
Tryptophan metabolism "via" nicotimic acid in patients with scleroderma.
Topics: Adult; Aged; Female; Humans; Kynurenine; Middle Aged; Niacinamide; Nicotinic Acids; Pyridoxine; Scleroderma, Localized; Scleroderma, Systemic; Tryptophan | 1976 |
Metabolism of 14C-labelled L-tryptophan, L-kynurenine and hydroxy-L-kynurenine in miners with scleroderma.
Topics: Carbon Dioxide; Humans; Kynurenine; Male; Middle Aged; Mining; Nicotinic Acids; Occupational Diseases; Quinolinic Acids; Scleroderma, Systemic; Tryptophan | 1977 |
5-Hydroxytryptamine and tryptamine pathways in scleroderma.
Topics: Adolescent; Adult; Aged; Female; Humans; Hydroxyindoleacetic Acid; Indoleacetic Acids; Indoles; Male; Middle Aged; Scleroderma, Localized; Scleroderma, Systemic; Serotonin; Tryptamines; Tryptophan | 1977 |
[Tryptophan metabolism in systemic scleroderma in comparison with immunological phenomena].
Topics: Antibodies, Antinuclear; Humans; Prognosis; Scleroderma, Systemic; Tryptophan | 1976 |
A mechanism for the formation in vivo of the 8-methyl ether of xanthurenic acid in humans.
Topics: Adult; Female; Humans; Kynurenic Acid; Kynurenine; Male; Methionine; Methyl Ethers; Middle Aged; Pellagra; Scleroderma, Systemic; Time Factors; Tryptophan; Xanthurenates | 1975 |
The uptake of 14C-labeled hydroxyanthranilic acid and enantiomers of tryptophan, kynurenine, and hydroxykynurenine in human blood.
Topics: 3-Hydroxyanthranilic Acid; Adult; Female; Humans; Isomerism; Kynurenine; Middle Aged; ortho-Aminobenzoates; Scleroderma, Systemic; Tryptophan | 1975 |
L-tryptophan syndrome: histologic features of scleroderma-like skin changes.
Topics: Adult; Biopsy; Eosinophilia-Myalgia Syndrome; Female; Humans; Middle Aged; Scleroderma, Systemic; Skin; Syndrome; Tryptophan | 1992 |
Tryptophan metabolism via the kynurenine pathway in patients with the eosinophilia-myalgia syndrome.
Topics: Adrenal Cortex Hormones; Adult; Aged; Eosinophilia-Myalgia Syndrome; Female; Humans; Interferon-gamma; Kynurenine; Male; Middle Aged; Quinolinic Acid; Scleroderma, Systemic; Tryptophan | 1992 |
L-tryptophan ingestion does not induce progressive systemic sclerosis (scleroderma).
Topics: Female; Humans; Middle Aged; Retrospective Studies; Scleroderma, Systemic; Tryptophan | 1992 |
Alterations in tryptophan metabolism in the toxic oil syndrome and in the eosinophilia-myalgia syndrome.
Topics: Arthritis, Rheumatoid; Biopterins; Brassica; Eosinophilia-Myalgia Syndrome; Fatty Acids, Monounsaturated; Humans; Kynurenine; Neopterin; Plant Oils; Quinolinic Acid; Quinolinic Acids; Rapeseed Oil; Reference Values; Scleroderma, Systemic; Syndrome; Tryptophan | 1992 |
Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan.
Topics: Adult; Aged; Eosinophilia; Fascia; Fasciitis; Female; Humans; Hydroxyindoleacetic Acid; Kynurenine; Male; Middle Aged; Muscles; Scleroderma, Systemic; Skin; Tryptophan | 1990 |
[A case from practice (233). Eosinophilic myalgia syndrome].
Topics: Diagnosis, Differential; Eosinophilia-Myalgia Syndrome; Female; Humans; Middle Aged; Scleroderma, Systemic; Tryptophan | 1991 |
[Eosinophilia-myalgia syndrome and L-tryptophan intake].
Topics: Biopsy; Diagnosis, Differential; Drug Eruptions; Eosinophilia; Female; Humans; Long-Term Care; Middle Aged; Neuromuscular Diseases; Scleroderma, Systemic; Skin; Syndrome; Tryptophan | 1991 |
[Tryptophan-induced fasciitis-scleroderma-eosinophilia syndrome].
Topics: Aged; Creatine Kinase; Diagnosis, Differential; Eosinophilia; Fasciitis; Female; Fructose-Bisphosphate Aldolase; Glucocorticoids; Humans; Hydroxychloroquine; Methotrexate; Middle Aged; Scleroderma, Systemic; Skin; Syndrome; Time Factors; Tryptophan | 1991 |
Scleroderma-like fasciitis without eosinophilia after L-tryptophan ingestion.
Topics: Diagnosis, Differential; Eosinophilia; Fasciitis; Humans; Leukocyte Count; Male; Middle Aged; Scleroderma, Systemic; Tryptophan | 1991 |
[Eosinophilia-myalgia syndrome].
Topics: Aged; Biopsy; Electromyography; Eosinophilia; Female; Humans; Middle Aged; Muscles; Neuromuscular Diseases; Parkinson Disease; Scleroderma, Systemic; Skin; Sleep Initiation and Maintenance Disorders; Syndrome; Tryptophan | 1991 |
[Eosinophilia-myalgia syndrome after L-tryptophan intake].
Topics: Depressive Disorder; Diagnosis, Differential; Dose-Response Relationship, Drug; Eosinophilia; Female; Humans; Middle Aged; Muscles; Neuromuscular Diseases; Scleroderma, Systemic; Skin; Sleep Initiation and Maintenance Disorders; Syndrome; Tryptophan | 1991 |
Postmortem studies of the heart in three fatal cases of the eosinophilia-myalgia syndrome.
Topics: Aged; Autopsy; Chemoreceptor Cells; Coronary Vessels; Eosinophilia; Fibromuscular Dysplasia; Heart; Heart Conduction System; Humans; Male; Middle Aged; Muscular Diseases; Myocardium; Pain; Scleroderma, Systemic; Syndrome; Tryptophan | 1991 |
Scleroderma and L-tryptophan: a possible explanation of the eosinophilia-myalgia syndrome.
Topics: Adult; Aged; Eosinophilia; Fasciitis; Female; Humans; Kynurenine; Middle Aged; Myositis; Prednisone; Scleroderma, Systemic; Skin; Syndrome; Tryptophan | 1990 |
[Eosinophilia-myalgia syndrome following administration of a L-tryptophan preparation].
Topics: Diagnosis, Differential; Eosinophilia; Female; Humans; Middle Aged; Muscular Diseases; Pain; Scleroderma, Systemic; Syndrome; Tryptophan | 1990 |
Development of diffuse fasciitis with eosinophilia during L-tryptophan treatment: demonstration of elevated type I collagen gene expression in affected tissues. A clinicopathologic study of four patients.
Topics: Aged; Collagen; Eosinophilia; Erythema; Fasciitis; Female; Gene Expression; Humans; Middle Aged; Muscular Diseases; Nucleic Acid Hybridization; Pain; Scleroderma, Systemic; Skin; Syndrome; Tryptophan | 1990 |
L-tryptophan ingestion associated with eosinophilic fasciitis but not progressive systemic sclerosis.
Topics: Adult; Aged; Antibodies, Antinuclear; Eosinophilia; Fasciitis; Female; Humans; Hypothyroidism; Middle Aged; Muscular Diseases; Pain; Prospective Studies; Retrospective Studies; Scleroderma, Localized; Scleroderma, Systemic; Syndrome; Tryptophan | 1990 |
Tryptophan metabolism as affected by anovulatory agents.
Topics: Aminohippuric Acids; Chlorotrianisene; Diethylstilbestrol; Estrogens; Female; Humans; Isoniazid; Kynurenine; Male; Menstruation; Mestranol; Niacinamide; Nicotinic Acids; Norethynodrel; Ovulation; Pregnancy; Progesterone; Pyridoxine; Scleroderma, Systemic; Tryptophan; Urinary Bladder Neoplasms; Vitamin B 6 Deficiency; Xanthurenates | 1969 |
Tryptophan metabolism in man (with special reference to rheumatoid arthritis and scleroderma).
Topics: Arthritis, Rheumatoid; Aspirin; Cystinuria; Drug Synergism; Edetic Acid; Humans; Kynurenic Acid; Kynurenine; Methods; Niacinamide; Penicillamine; Pyridoxine; Scleroderma, Systemic; Tryptophan; Xanthurenates | 1973 |
Scleroderma-like lesions in multiple myeloma.
Topics: Amyloidosis; Histocytochemistry; Humans; Indoles; Intestine, Small; Kidney; Male; Microscopy, Electron; Middle Aged; Multiple Myeloma; Muscles; Scleroderma, Systemic; Skin; Tryptophan | 1972 |
Tryptophan metabolism in man, rat and pig. Determination of tryptophan-pyrrolase and kinureninase in liver.
Topics: Adult; Animals; Dicarboxylic Acids; Erythema; Female; Humans; Hydrolases; Kynurenine; Lichen Planus; Liver; Lupus Erythematosus, Systemic; Male; Middle Aged; Parapsoriasis; Pellagra; Porphyrias; Pyridines; Rats; Scleroderma, Systemic; Skin Diseases; Species Specificity; Swine; Tryptophan; Tryptophan Oxygenase | 1972 |
Tryptophan to niacin pathway in scleroderma and in dermatomyositis.
Topics: Adolescent; Adult; Aged; Dermatomyositis; Female; Humans; Hydrolases; Indoleacetic Acids; Indoles; Kynurenine; Male; Middle Aged; Nicotinic Acids; Scleroderma, Localized; Scleroderma, Systemic; Skatole; Tryptophan | 1973 |
Metabolism of C 14 labeled enantiomers of tryptophan, kynurenine and hydroxykynurenine in humans with scleroderma.
Topics: Adult; Carbon Dioxide; Carbon Isotopes; Female; Humans; Kynurenic Acid; Kynurenine; Middle Aged; Phenols; Picolinic Acids; Respiration; Scleroderma, Localized; Scleroderma, Systemic; Stereoisomerism; Time Factors; Tryptophan; Xanthurenates | 1972 |
[Clinical and physiopathological findings in lichen sclerosus et atrophicus].
Topics: Adult; Aged; Antibodies, Antinuclear; Autoantibodies; Autonomic Nervous System; Chronaxy; Dermatomycoses; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Pyridoxine; Scleroderma, Systemic; Skin Diseases; Tryptophan; Xanthurenates | 1968 |
[Pseudoscleroderma].
Topics: Arteriosclerosis; Arthritis; Dermatomyositis; Diagnosis, Differential; Humans; Hypopituitarism; Porphyrias; Raynaud Disease; Scleredema Adultorum; Scleroderma, Systemic; Skin Diseases; Tryptophan; Werner Syndrome | 1967 |
[Studies on the excretion of tryptophan metabolites in patients with circumscript and progressive scleroderma].
Topics: Adult; Aged; Female; Humans; Kynurenic Acid; Kynurenine; Male; Middle Aged; ortho-Aminobenzoates; Scleroderma, Systemic; Tryptophan; Xanthurenates | 1968 |
Tryptophan metabolism in a patient with phenylketonuria and scleroderma: a proposed explanation of the indole defect in phenylketonuria.
Topics: Chromatography, Paper; Humans; In Vitro Techniques; Indican; Indoles; Infant; Male; Phenylketonurias; Scleroderma, Systemic; Tryptophan; Urine | 1966 |